Ability Pharmaceuticals
Ability Pharmaceuticals is a Catalan biopharmaceutical company developing innovative oral autophagy-inducing anticancer compounds. Their lead compound, ABTL0812, is in a Phase 2b clinical trial for metastatic pancreatic cancer, aiming to demonstrate superior efficacy to standard treatments. The company seeks to make ABTL0812 available to patients by 2028.
Buy Funded Startups lists
Funding Round:
Funding Amount: €7M
Date: 11-Mar-2024
Investors: CTI Life Sciences Fund, Inveready, EIC Fund, Fitalent, CDTI Innvierte, family offices, founders
Markets: Biopharmaceutical, Oncology, Pharmaceutical
HQ: Barcelona, Catalonia, Spain
Founded:
Website: https://www.abilitypharma.com/
Leave a Comment
Comments
No comments yet.